Powered by

ObsEva SA to Participate in JP Morgan Healthcare Conference January 7-10, 2019

Jan 01, 2019 - GlobeNewswire

Geneva, Switzerland and Boston January 2, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy, today announced that Company Management will be participating in the JP Morgan Healthcare Conference taking place January 7-10, 2019 in San Francisco.  ObsEva will present on Tuesday, January 8, 2019 at 4 p.m. P...